Airflow limitation in smokers is associated with arterial stiffness: The Nagahama Study

Atherosclerosis

Volumn 232, Issue 1, 2014, Pages 59-64

  Tabara, Yasuharu ^a   Muro, Shigeo ^a   Takahashi, Yoshimitsu ^b   Setoh, Kazuya ^a   Kawaguchi, Takahisa ^a   Terao, Chikashi ^a   Kosugi, Shinji ^b   Sekine, Akihiro ^a   Yamada, Ryo ^a   Nakayama, Takeo ^b   Mishima, Michiaki ^a   Matsuda, Fumihiko ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

Author keywords

Airflow limitation; Arterial stiffness; Chronic obstructive pulmonary diseases; Pulse wave velocity; Smoking

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; HIGH SENSITIVITY C REACTIVE PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; AIRFLOW LIMITATION; ANKLE BRACHIAL INDEX; ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; BRACHIAL TO ANKLE PULSE WAVE VELOCITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HYPERTENSION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE WAVE; RESPIRATORY AIRFLOW; RISK FACTOR; SMOKING; SMOKING HABIT; STRUCTURED QUESTIONNAIRE;

AIRFLOW LIMITATION; ARTERIAL STIFFNESS; CHRONIC OBSTRUCTIVE PULMONARY DISEASES; PULSE WAVE VELOCITY; SMOKING;

AGED; BRACHIAL ARTERY; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYPERTENSION; JAPAN; LINEAR MODELS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RISK FACTORS; SMOKING; TOBACCO PRODUCTS; VASCULAR STIFFNESS; VITAL CAPACITY;

EID: 84891609391     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.10.020     Document Type: Article

References (35)

1. Hole D.J., Watt G.C., Davey-Smith G., Hart C.L., Gillis C.R., Hawthorne V.M. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996, 313:711-715.
2. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global Burden of Disease Study. Lancet 1997, 349:1498-1504.
3. Hozawa A., Billings J.L., Shahar E., Ohira T., Rosamond W.D., Folsom A.R. Lung function and ischemic stroke incidence: the Atherosclerosis Risk in Communities Study. Chest 2006, 130:1642-1649.
4. Engström G., Lind P., Hedblad B., et al. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 2002, 106:2555-2560.
5. Agarwal S.K., Heiss G., Barr R.G., et al. Airflow obstruction, lung function, and risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study. Eur J Heart Fail 2012, 14:414-422.
6. Mannino D.M., Thorn D., Swensen A., Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008, 32:962-969.
7. Tomiyama H., Okazaki R., Koji Y., et al. Elevated C-reactive protein: a common marker for atherosclerotic cardiovascular risk and subclinical stages of pulmonary dysfunction and osteopenia in a healthy population. Atherosclerosis 2005, 178:187-192.
8. Sin D.D., Man S.F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseasesα the potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003, 107:1514-1519.
9. Engström G., Hedblad B., Valind S., Janzon L. Asymptomatic leg and carotid atherosclerosis in smokers is related to degree of ventilatory capacity: longitudinal and cross-sectional results from 'Men born in 1914', Sweden. Atherosclerosis 2001, 155:237-243.
10. Iwamoto H., Yokoyama A., Kitahara Y., et al. Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med 2009, 179:35-40.
11. Mills N.L., Miller J.J., Anand A., et al. Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk. Thorax 2008, 63:306-311.
12. Cao J.J., Thach C., Manolio T.A., et al. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation 2003, 108:166-170.
13. Cao J.J., Arnold A.M., Manolio T.A., et al. Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation 2007, 116:32-38.
14. Barr R.G., Ahmed F.S., Carr J.J., et al. Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study. Eur Respir J 2012, 39:846-854.
15. Schroeder E.B., Welch V.L., Evans G.W., Heiss G. Impaired lung function and subclinical atherosclerosis. The ARIC Study. Atherosclerosis 2005, 180:367-373.
16. Howard G., Wagenknecht L.E., Burke G.L., et al. Cigarette smoking and progression of atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. JAMA 1998, 279:119-124.
17. Prescott E., Hippe M., Schnohr P., Hein H.O., Vestbo J. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 1998, 316:1043-1047.
18. Whitley E., Lee I.M., Sesso H.D., Batty G.D. Association of cigarette smoking from adolescence to middle-age with later total and cardiovascular disease mortality: the harvard alumni health study. JAm Coll Cardiol 2012, 60:1839-1840.
19. Ambrose J.A., Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. JAm Coll Cardiol 2004, 43:1731-1737.
20. Yamashina A., Tomiyama H., Takeda K., et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002, 25:359-364.
21. Tanaka H., Munakata M., Kawano Y., et al. Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. JHypertens 2009, 27:2022-2027.
22. Sugawara J., Hayashi K., Yokoi T., et al. Brachial-ankle pulse wave velocity: an index of central arterial stiffnessα. JHum Hypertens 2005, 19:401-406.
23. Tockman M.S., Comstock G.W. Respiratory risk factors and mortality: longitudinal studies in Washington County, Maryland. Am Rev Respir Dis 1989, 140:S56-S63.
24. Young R.P., Hopkins R., Eaton T.E. Forced expiratory volume in one second: not just a lung function test but a marker of pre-mature death from all causes. Eur Respir J 2007, 30:616-622.
25. Kasahara Y., Tuder R.M., Cool C.D., Lynch D.A., Flores S.C., Voelkel N.F. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 2001, 163:737-744.
26. Kanazawa H., Asai K., Hirata K., Yoshikawa J. Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Am J Med 2003, 114:354-358.
27. Kasahara Y., Tuder R.M., Taraseviciene-Stewart L., et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. JClin Invest 2000, 106:1311-1319.
28. Gerber H.P., Dixit V., Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. JBiol Chem 1998, 273:13313-13316.
29. Thaikoottathil J.V., Martin R.J., Zdunek J., Weinberger A., Rino J.G., Chu H.W. Cigarette smoke extract reduces VEGF in primary human airway epithelial cells. Eur Respir J 2009, 33:835-843.
30. Górecka D., Bednarek M., Nowiński A., Puścińska E., Goljan-Geremek A., Zieliński J. Diagnosis of airflow limitation combined with smoking cessation advice increases stop-smoking rate. Chest 2003, 123:1916-1923.
31. Bednarek M., Gorecka D., Wielgomas J., et al. Smokers with airway obstruction are more likely to quit smoking. Thorax 2006, 61:869-873.
32. Calverley P.M. COPD: early detection and intervention. Chest 2000, 117:365S-371S.
33. Mannino D.M., Gagnon R.C., Petty T.L., Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000, 160:1683-1689.
34. Lamprecht B., McBurnie M.A., Vollmer W.M., et al. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest 2011, 139:752-763. BOLD Collaborative Research Group.
35. Anton M.M., Cortez-Cooper M.Y., DeVan A.E., Neidre D.B., Cook J.N., Tanaka H. Cigarette smoking, regular exercise, and peripheral blood flow. Atherosclerosis 2006, 185:201-205.